How to Get Anxiety Medication for Teens: A Parent’s Roadmap

Some teens struggle to get their head above water with anxiety symptoms. The best coping skills in the world can’t help when their stress baseline is elevated. Everything intended to help can just feel like more noise. Anxiety medication for teens can help in these cases.

By lowering stress, anxiety medication helps make therapy and coping skills effective. It means your teen can actually feel empowered by seeing results from the mental health work they’re doing. Knowing when and how to get anxiety prescriptions for a teen, which options are actually FDA-approved, and what to expect along the way are game changers when it comes to teen mental health.

How to Know If Anxiety Medication Might Be Right for Your Teen

How do I know if my teen needs medication for anxiety? There’s no one-size-fits-all answer. Every teen experiences anxiety differently, and the decision to start medication depends on the severity of symptoms, level of impairment, response to therapy, and individual circumstances. Here are some telltale signs it’s time to explore the medication route:

• Severe life disruptions: Severe anxiety has a way of shrinking a teen’s world. Your teen may be refusing to go to school, tanking their grades, or struggling with activities they used to love. They may also be diving into extreme withdrawal and isolation even though they’ve been working with a therapist or counselor.
• Therapy plateaus or stagnant progress: Some teens understand and can describe coping strategies learned in therapy but may struggle to use those skills effectively when anxiety becomes overwhelming. While cognitive behavioral therapy (CBT) skills have the power to change habits and lives, a teen who is deep in anxiety may be too panicky or overwhelmed to actually apply them in real life.
• Physical symptoms: Anxiety can also cause significant physical symptoms, including panic attacks, sleep difficulties, headaches, stomachaches, fatigue, and muscle tension. When these symptoms significantly impair daily functioning, discussing additional treatment options with a mental health professional may be appropriate.
• Severe symptoms tangled up with other mental health conditions: Anxiety rarely travels alone. In a nationally representative survey of more than 10,000 U.S. teens, about 40% of those who met criteria for one class of mental health condition also met criteria for another.¹ When anxiety occurs alongside conditions such as depression, ADHD, OCD, or trauma-related symptoms, treatment may require a combination of therapeutic, behavioral, educational, and sometimes medication-based interventions.

You haven’t failed your child if the therapy you’ve chosen hasn’t “solved” the problem of anxiety. This also isn’t a failure on the part of your child or their therapist. It may mean that the treatment plan needs to be adjusted or expanded to better meet your teen’s needs. Rest assured, you’re not the only parent facing this.

As Jamie Waarbroek, a Nurse Practitioner at Neuro Wellness Spa, puts it:

“As a PMHNP specializing in adolescent mental health, I often remind families that medication is not about changing who a teen is. When anxiety becomes severe enough to interfere with daily functioning, medication can help reduce symptom burden and create the opportunity for therapy, coping skills, and resilience to take hold.”

A CDC survey finds that four in 10 American high school students report prolonged feelings of sadness or hopelessness.² Anxiety levels among children and teens are climbing too. Anxiety disorders are the most common mental health condition in adolescence, and national survey data puts the lifetime rate at 31.9% for teens ages 13 to 18.¹ For roughly 8% of teens, that anxiety comes with severe impairment.¹ Childhood anxiety also tends to start earlier than most parents expect, with a median age of onset around 6 years old.¹ Hospital admissions for suicidal teenagers have also doubled in recent years.³ Getting an assessment to see if medication is the right next step is important.

Related: Understanding and Addressing Teen Anxiety: Signs, Causes, Symptoms, and Treatment

The Role of an Assessment, Who Can Evaluate Your Teen, and What to Expect

Can a therapist prescribe anxiety medication to a teenager? In most cases, no. Therapists and psychologists provide counseling, but prescribing is handled by a medical provider like a psychiatrist or a psychiatric mental health nurse practitioner (PMHNP). Therapy remains an important part of anxiety treatment and may be used alone or alongside medication, depending on the teen’s needs. Neuro Wellness Spa offers collaborative care for adolescent mental health that works alongside everything you’re already doing for your teen.

The first step in exploring the medication route for your teen’s anxiety is an adolescent psychiatric evaluation for anxiety. Teen anxiety treatment starts with understanding exactly what you’re treating.

What happens during a teen psychiatric evaluation?

1. Evaluation: When you choose NWS, the evaluation process will be overseen by a qualified psychiatrist or psychiatric-mental health nurse practitioner (PMHNP).
2. Clinical Assessments: During the evaluation process, we’ll work toward confirming a generalized anxiety disorder diagnosis and rule out other possibilities like attention deficit hyperactivity disorder (ADHD), obsessive-compulsive disorder (OCD), depressive disorders, trauma-related disorders, substance use concerns, and bipolar spectrum disorders. Validated screening tools help guide this. The SCARED is designed for children and teens ages 8 to 18 and screens for generalized anxiety, separation anxiety, panic symptoms, social anxiety, and school avoidance.⁴ The GAD-7 is a shorter questionnaire also used with older teens. These tools support the diagnosis, but they never replace a clinician’s judgment.
3. Clinical & Collateral Interviews: The assessment typically includes interviews with the teen and parent(s) or guardian(s), a review of psychiatric and medical history, evaluation of current symptoms and functional impairment, and discussion of academic, social, and family functioning. When appropriate, information may also be obtained from therapists, primary care providers, or school personnel to develop a comprehensive and individualized treatment plan.

Which Medications Are FDA Approved for Teens?

Here’s something that surprises a lot of parents. Only a limited number of medications are FDA approved specifically for anxiety disorders in children and adolescents. That doesn’t mean anxiety meds don’t work for this age group. It means the approval paperwork hasn’t caught up to how these medications are actually used.

FDA approval requires a drug maker to run trials proving a medication is both safe and effective for a specific condition in a specific age group. That process is expensive and slow, and pediatric trials are especially hard to run. As a result, some medications with evidence supporting their use in pediatric anxiety are commonly prescribed despite not having a specific FDA indication for that condition or age group.

Currently, duloxetine and escitalopram carry FDA approval for generalized anxiety disorder in certain pediatric age groups:

• Duloxetine (Cymbalta) is approved for generalized anxiety disorder in patients 7 to 17.⁵ It belongs to a class called serotonin norepinephrine reuptake inhibitors.
• Escitalopram (Lexapro) was approved for generalized anxiety disorder in patients 7 and older in 2023.⁶ It’s a selective serotonin reuptake inhibitor, or SSRI.

Medication	Class	FDA approved for	Ages
Duloxetine (Cymbalta)	SNRI	Generalized anxiety disorder	7 to 17 5
Escitalopram (Lexapro)	SSRI	Generalized anxiety disorder	7 and up 6
Sertraline (Zoloft)	SSRI	OCD	6 and up 7
Fluoxetine (Prozac)	SSRI	OCD	7 and up 7
Fluvoxamine (Luvox)	SSRI	OCD	8 and up 7

Three other medications are FDA approved for OCD in children and teens rather than for anxiety itself: sertraline (Zoloft) for ages 6 and up, fluoxetine (Prozac) for ages 7 and up, and fluvoxamine (Luvox) for ages 8 and up.⁷

Related: Anxiety Medication: Your Guide to Effective Treatment Strategies

What “off-label” actually means

When a medication is FDA approved for one use, a prescriber can legally use it for another when the clinical evidence supports it. This is standard, legal, and extremely common in pediatric care. Most SSRIs commonly prescribed for teen anxiety are technically off-label for that use, even though selective serotonin reuptake inhibitors are the first-line medication treatment for pediatric anxiety and carry the strongest evidence base.⁸ Among SSRIs, fluoxetine, sertraline, and escitalopram have some of the strongest evidence supporting their use in pediatric anxiety disorders.⁸

So if a prescriber recommends Zoloft for your teen’s anxiety, that isn’t a shortcut. It’s a decision grounded in a large body of research that simply predates or sits outside the FDA label.

If SSRIs don’t work

If an adequate trial of an SSRI is ineffective or poorly tolerated, alternative options may include another SSRI or an SNRI such as duloxetine or venlafaxine, depending on the individual’s clinical presentation.⁹ Buspirone is sometimes considered as an off-label option, though the pediatric evidence behind it is weaker than it is for SSRIs, so it’s usually an add-on rather than a first choice.⁹ Benzodiazepines are rarely used in teens because of dependency risk.

There’s no single best anxiety medication for every teen. The right one depends on your teen’s symptoms, whether they also have depression or other conditions, how they respond, and what side effects they can live with. Many of these medications also treat depression, which matters because anxiety and depression so often show up together.

Related: Antidepressants Not Working? Here’s What To Do Next

Common Teen Medications, Side Effects and How We Monitor Treatment

What is the most common anxiety medication prescribed to teens? Practitioners prioritize well-studied selective serotonin reuptake inhibitors (SSRIs) like sertraline and fluoxetine, sold under the brand names Zoloft and Prozac. Escitalopram (Lexapro) is also commonly prescribed. These medications are among the most well-studied and commonly prescribed SSRIs for children and adolescents with anxiety disorders, with strong evidence supporting their efficacy and tolerability.⁸

SSRIs increase serotonin activity in the brain, which plays an important role in regulating anxiety, mood, and stress responses. Because they also treat depression, they can address both conditions when a teen is dealing with anxiety and major depressive disorder at once.

Related: Antidepressants for Teens: A Parent’s Guide

What about dependency?

This is where SSRIs differ sharply from sedatives. Unlike some prescription drugs, SSRIs don’t create euphoria or trigger dopamine surges in brain reward pathways that can drive drug-seeking behavior.¹⁰ SSRIs are not considered addictive and do not produce the cravings or drug-seeking behaviors associated with substances of misuse.¹⁰

Dependency-forming sedatives like benzodiazepines are rarely used when treating anxiety in teens for exactly this reason. That said, stopping an SSRI abruptly can cause discontinuation symptoms, so these medications are always tapered with a prescriber rather than stopped cold.

What side effects should I actually expect?

Side effects are real and worth knowing about. Roughly 1 in 10 children and teens experience them.⁸ The most common ones show up early and include nausea, stomach upset, headaches, trouble sleeping, restlessness or jitteriness, and changes in appetite or energy.

Here’s the encouraging part. In the largest SSRI trial in pediatric anxiety, insomnia, restlessness, nausea, abdominal pain, and dry mouth all decreased over 12 weeks of treatment, which suggests many of these effects are temporary and fade as the body adjusts.¹¹ Some, like weight changes, emerge later and are tracked over time. Often side effects are managed by adjusting the dose, though sometimes a change in medication is needed.⁸

The black box warning, explained plainly

Every antidepressant carries an FDA boxed warning, the agency’s most serious type of warning. It states that antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies, and that all patients taking them should be closely monitored for clinical worsening and for the emergence of suicidal thoughts and behaviors.⁶

That warning applies to the entire class, including every medication named above. It’s worth taking seriously, and it’s also worth understanding in context. In pediatric anxiety studies, treatment-emergent suicidal thoughts and behaviors have been uncommon, and studies have generally not found a significantly increased risk compared with placebo.⁹

What this means practically is that monitoring matters most in the first few weeks and after any dose change. Your prescriber will schedule frequent early check-ins for exactly this reason. Call right away if you notice agitation, new irritability, sleep disruption, or any talk of self-harm.

One more thing your prescriber will do before starting: screen your teen for any personal or family history of bipolar disorder.⁶ In individuals with an underlying bipolar disorder, antidepressants may contribute to the emergence of manic or hypomanic symptoms, making screening an important part of the evaluation process.

Your role as the parent

Teenagers are still developing the executive function skills that make consistent daily habits automatic. That’s not a character flaw, it’s neurology. Parents and caregivers are encouraged to help monitor medication adherence, particularly in younger adolescents. Depending on the teen’s age and maturity level, this may include supervising doses, using reminders, or tracking medication use. Keep the medication somewhere you control, watch doses go down, and track them. Consistency is a large part of whether antidepressant treatment works.

How long until we know if it’s working?

Small changes can appear within about two weeks, but clinically meaningful improvement typically shows up around week six.⁷ Rather than the old rule of starting low and staying there, current practice is to start at a low dose and increase steadily as your teen tolerates it, since under-dosing is a common reason medication seems to fail.⁷

Routine follow-up visits let your teen, you, and the practitioner track progress together. Your medication plan gets adjusted based on what you’re all seeing at home, at school, and in session.

Related: Do Antidepressants Give Immediate Relief for Depression?

Why Medication and Therapy Work Better Together

If you take one thing from this article, make it this. For many children and adolescents with moderate to severe anxiety, research suggests that a combination of therapy and medication may provide greater symptom improvement than either treatment alone.¹²

The largest trial on this question followed 488 kids and teens ages 7 to 17 with generalized anxiety disorder, separation anxiety, or social anxiety. Researchers compared cognitive behavioral therapy alone, sertraline alone, both together, and a placebo. After 12 weeks, 80.7% of the teens receiving both treatments were much or very much improved, compared to 59.7% for therapy alone and 54.9% for medication alone.¹²

Read those numbers again. Therapy and medication each worked. Together they worked substantially better than either one by itself.

Here’s why that makes sense. Medication and therapy do different jobs, on different timelines. Some teens experience improvement in physical anxiety symptoms within several weeks of starting medication, while therapy focuses on developing long-term coping skills and strategies that can continue to benefit them over time.

A teen who is white-knuckling through constant panic often can’t absorb what a therapist is teaching. Lower the physical intensity first, and suddenly those CBT tools become usable. That’s the whole idea behind combined anxiety treatment. Medication doesn’t replace the work. It makes the work possible.

Because no two adolescents experience mental health challenges in exactly the same way, treatment should be personalized while actively involving family members in the process. As Waarbroek explains:

“The most effective treatment plans are individualized, evidence-based, and developed collaboratively with teens and their families.”

This is also why NWS keeps prescribers and therapists talking to each other rather than operating in separate lanes.

Related: Anxiety Therapy and Integrated Strategies

How NWS Teen Psychiatry Supports Your Family

Neuro Wellness Spa implements evidence-based teen anxiety treatment. Every plan is built around the teen in front of us, not a template. Our compassionate, specialized care model is designed to make the process clearer for families who feel like they’re guessing.

We employ specialized adolescent prescribers, which means our clinicians understand the nuances of youth mental health and the dosing practices specific to teens. That expertise matters when so much of pediatric prescribing sits outside the FDA label and depends on real familiarity with the research.

Our teen psychiatry and medication management isn’t meant to replace therapy. We offer collaborative care that aligns directly with your teen’s therapist, so the work your teen is doing in session and the work their medication is doing point in the same direction. Your family gets continuous support and monitoring throughout stabilization, not just a prescription and a follow-up in three months.

References

1. Merikangas KR, He JP, Burstein M, et al. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9. https://pubmed.ncbi.nlm.nih.gov/20855043/
2. Centers for Disease Control and Prevention. (2024, September 29). 2023 Youth Risk Behavior Survey results. https://www.cdc.gov/yrbs/results/2023-yrbs-results.html
3. Anderson TL, Valiauga R, Tallo C, Hong CB, Manoranjithan S, Domingo C, Paudel M, Untaroiu A, Barr S, Goldhaber K. Contributing Factors to the Rise in Adolescent Anxiety and Associated Mental Health Disorders: A Narrative Review of Current Literature. J Child Adolesc Psychiatr Nurs. 2025 Feb;38(1):e70009. https://pmc.ncbi.nlm.nih.gov/articles/PMC11683866/
4. Oregon Health & Science University. (2019). Screen for Child Anxiety Related Emotional Disorders (SCARED): Parent and child version [PDF]. https://www.ohsu.edu/sites/default/files/2019-06/SCARED-form-Parent-and-Child-version.pdf
5. U.S. Food and Drug Administration. CYMBALTA (duloxetine) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/021427s052lbl.pdf
6. U.S. Food and Drug Administration. LEXAPRO (escitalopram) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/021365s041lbl.pdf
7. Lurie Children’s Hospital RAMP. SSRIs. https://ramp.luriechildrens.org/en/conditions-and-treatments/medications/ssris/
8. American Academy of Pediatrics. Antidepressants: Pediatric Mental Health Minute Series. https://www.aap.org/en/patient-care/mental-health-minute/antidepressants/
9. Nicotra CM, Strawn JR. Advances in pharmacotherapy for pediatric anxiety disorders. Child Adolesc Psychiatr Clin N Am. 2023;32(3):573-587. https://www.childpsych.theclinics.com/article/S1056-4993(23)00017-2/fulltext
10. Chiappini S, Vickers-Smith R, Guirguis A, Corkery JM, Martinotti G, Schifano F. A Focus on Abuse/Misuse and Withdrawal Issues with Selective Serotonin Reuptake Inhibitors (SSRIs): Analysis of Both the European EMA and the US FAERS Pharmacovigilance Databases. Pharmaceuticals (Basel). 2022 May 1;15(5):565. https://pmc.ncbi.nlm.nih.gov/articles/PMC9147015/
11. Strawn JR, Mills JA, Poweleit EA, Ramsey LB, Croarkin PE. Adverse effects of antidepressant medications and their management in children and adolescents. Pharmacotherapy. 2023 Jul;43(7):675-690. https://pmc.ncbi.nlm.nih.gov/articles/PMC10378577/
12. Walkup JT, Albano AM, Piacentini J, et al. Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med. 2008;359(26):2753-2766. https://www.nejm.org/doi/full/10.1056/NEJMoa0804633